Cargando…

Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study

OBJECTIVES: To assess the coronary atherosclerosis profile by coronary computed tomography angiography (CTA) in patients with end-stage liver disease (ESLD) due to alcohol-related liver disease (ARLD) evaluated for liver transplantation (LT), in a retrospective matched case-controlled cohort study....

Descripción completa

Detalles Bibliográficos
Autores principales: Steinkohl, Fabian, Barbieri, Fabian, Senoner, Thomas, Strobl, Sylvia, Finkenstedt, Armin, Plank, Fabian, Langer, Christian, Beyer, Christoph, Birkl, Katharina, Widmann, Gerlig, Zoller, Heinz, Dichtl, Wolfgang, Friedrich, Guy, Tilg, Herbert, Feuchtner, Gudrun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755634/
https://www.ncbi.nlm.nih.gov/pubmed/32749590
http://dx.doi.org/10.1007/s00330-020-07037-8
_version_ 1783626390292135936
author Steinkohl, Fabian
Barbieri, Fabian
Senoner, Thomas
Strobl, Sylvia
Finkenstedt, Armin
Plank, Fabian
Langer, Christian
Beyer, Christoph
Birkl, Katharina
Widmann, Gerlig
Zoller, Heinz
Dichtl, Wolfgang
Friedrich, Guy
Tilg, Herbert
Feuchtner, Gudrun
author_facet Steinkohl, Fabian
Barbieri, Fabian
Senoner, Thomas
Strobl, Sylvia
Finkenstedt, Armin
Plank, Fabian
Langer, Christian
Beyer, Christoph
Birkl, Katharina
Widmann, Gerlig
Zoller, Heinz
Dichtl, Wolfgang
Friedrich, Guy
Tilg, Herbert
Feuchtner, Gudrun
author_sort Steinkohl, Fabian
collection PubMed
description OBJECTIVES: To assess the coronary atherosclerosis profile by coronary computed tomography angiography (CTA) in patients with end-stage liver disease (ESLD) due to alcohol-related liver disease (ARLD) evaluated for liver transplantation (LT), in a retrospective matched case-controlled cohort study. METHODS: One hundred forty patients (age 60.6 years ± 9.8, 20.7% females) who underwent coronary CTA were included. Seventy patients with ESLD due to ARLD (ESLD-alc) were propensity score (1:1) matched for age, gender, and the major 5 cardiovascular risk factors with healthy controls. CTA analysis included the following: stenosis severity according to CAD-RADS as (0) = no, (1) minimal < 25%, (2) mild 25–50%, (3) moderate 50–70%, and (4) severe > 70% stenosis, total mixed plaque burden weighted for non-calcified component (G-score) and high-risk plaque criteria (Napkin-Ring, low attenuation plaque, spotty calcification, positive remodeling). RESULTS: Prevalence of coronary artery disease (CAD) was high (84.4%) in the ESLD-alc group but similar to controls. Stenosis severity was similar (CAD-RADS, 1.9 vs. 2.2, p = 0.289). High-grade stenosis (> 70%) was observed in 12.5% of ESLD-alc patients. High-risk plaques were less frequent in the ESLD-alc cohort as compared to controls (4.5% vs. 37.5%, p < 0.001), and total mixed plaque burden was lower (G-score, 4.9 versus 7.4, p = 0.001). Plaque density was lower in controls (56.6HU ± 3.2 vs. 91.3HU ± 4.5, p = 0.007) indicating more lipid-rich in controls, but higher mixed fibro-calcific plaque component in those with alcohol-related ESLD. CONCLUSION: Patients with alcohol-related ESLD exhibit more mixed fibro-calcified plaques but less plaque with high-risk features and less fibro-fatty plaque burden, while total CAD prevalence is high. KEY POINTS: • Patients with ESLD prior to LT have a high total prevalence of CAD and stenosis severity, which is similar to those of healthy controls with an identical cardiovascular risk profile. • Patients with ESLD prior to LT due to alcohol abuse have more calcific but less fibro-fatty plaque and less high-risk plaque. • CTA seems to be a useful imaging technique for risk stratification prior to LT.
format Online
Article
Text
id pubmed-7755634
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-77556342020-12-28 Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study Steinkohl, Fabian Barbieri, Fabian Senoner, Thomas Strobl, Sylvia Finkenstedt, Armin Plank, Fabian Langer, Christian Beyer, Christoph Birkl, Katharina Widmann, Gerlig Zoller, Heinz Dichtl, Wolfgang Friedrich, Guy Tilg, Herbert Feuchtner, Gudrun Eur Radiol Cardiac OBJECTIVES: To assess the coronary atherosclerosis profile by coronary computed tomography angiography (CTA) in patients with end-stage liver disease (ESLD) due to alcohol-related liver disease (ARLD) evaluated for liver transplantation (LT), in a retrospective matched case-controlled cohort study. METHODS: One hundred forty patients (age 60.6 years ± 9.8, 20.7% females) who underwent coronary CTA were included. Seventy patients with ESLD due to ARLD (ESLD-alc) were propensity score (1:1) matched for age, gender, and the major 5 cardiovascular risk factors with healthy controls. CTA analysis included the following: stenosis severity according to CAD-RADS as (0) = no, (1) minimal < 25%, (2) mild 25–50%, (3) moderate 50–70%, and (4) severe > 70% stenosis, total mixed plaque burden weighted for non-calcified component (G-score) and high-risk plaque criteria (Napkin-Ring, low attenuation plaque, spotty calcification, positive remodeling). RESULTS: Prevalence of coronary artery disease (CAD) was high (84.4%) in the ESLD-alc group but similar to controls. Stenosis severity was similar (CAD-RADS, 1.9 vs. 2.2, p = 0.289). High-grade stenosis (> 70%) was observed in 12.5% of ESLD-alc patients. High-risk plaques were less frequent in the ESLD-alc cohort as compared to controls (4.5% vs. 37.5%, p < 0.001), and total mixed plaque burden was lower (G-score, 4.9 versus 7.4, p = 0.001). Plaque density was lower in controls (56.6HU ± 3.2 vs. 91.3HU ± 4.5, p = 0.007) indicating more lipid-rich in controls, but higher mixed fibro-calcific plaque component in those with alcohol-related ESLD. CONCLUSION: Patients with alcohol-related ESLD exhibit more mixed fibro-calcified plaques but less plaque with high-risk features and less fibro-fatty plaque burden, while total CAD prevalence is high. KEY POINTS: • Patients with ESLD prior to LT have a high total prevalence of CAD and stenosis severity, which is similar to those of healthy controls with an identical cardiovascular risk profile. • Patients with ESLD prior to LT due to alcohol abuse have more calcific but less fibro-fatty plaque and less high-risk plaque. • CTA seems to be a useful imaging technique for risk stratification prior to LT. Springer Berlin Heidelberg 2020-08-04 2021 /pmc/articles/PMC7755634/ /pubmed/32749590 http://dx.doi.org/10.1007/s00330-020-07037-8 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Cardiac
Steinkohl, Fabian
Barbieri, Fabian
Senoner, Thomas
Strobl, Sylvia
Finkenstedt, Armin
Plank, Fabian
Langer, Christian
Beyer, Christoph
Birkl, Katharina
Widmann, Gerlig
Zoller, Heinz
Dichtl, Wolfgang
Friedrich, Guy
Tilg, Herbert
Feuchtner, Gudrun
Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study
title Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study
title_full Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study
title_fullStr Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study
title_full_unstemmed Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study
title_short Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study
title_sort coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary cta study
topic Cardiac
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755634/
https://www.ncbi.nlm.nih.gov/pubmed/32749590
http://dx.doi.org/10.1007/s00330-020-07037-8
work_keys_str_mv AT steinkohlfabian coronaryatherosclerosisprofileinpatientswithendstageliverdiseasepriortolivertransplantationduetoalcoholicfattyliveracoronaryctastudy
AT barbierifabian coronaryatherosclerosisprofileinpatientswithendstageliverdiseasepriortolivertransplantationduetoalcoholicfattyliveracoronaryctastudy
AT senonerthomas coronaryatherosclerosisprofileinpatientswithendstageliverdiseasepriortolivertransplantationduetoalcoholicfattyliveracoronaryctastudy
AT stroblsylvia coronaryatherosclerosisprofileinpatientswithendstageliverdiseasepriortolivertransplantationduetoalcoholicfattyliveracoronaryctastudy
AT finkenstedtarmin coronaryatherosclerosisprofileinpatientswithendstageliverdiseasepriortolivertransplantationduetoalcoholicfattyliveracoronaryctastudy
AT plankfabian coronaryatherosclerosisprofileinpatientswithendstageliverdiseasepriortolivertransplantationduetoalcoholicfattyliveracoronaryctastudy
AT langerchristian coronaryatherosclerosisprofileinpatientswithendstageliverdiseasepriortolivertransplantationduetoalcoholicfattyliveracoronaryctastudy
AT beyerchristoph coronaryatherosclerosisprofileinpatientswithendstageliverdiseasepriortolivertransplantationduetoalcoholicfattyliveracoronaryctastudy
AT birklkatharina coronaryatherosclerosisprofileinpatientswithendstageliverdiseasepriortolivertransplantationduetoalcoholicfattyliveracoronaryctastudy
AT widmanngerlig coronaryatherosclerosisprofileinpatientswithendstageliverdiseasepriortolivertransplantationduetoalcoholicfattyliveracoronaryctastudy
AT zollerheinz coronaryatherosclerosisprofileinpatientswithendstageliverdiseasepriortolivertransplantationduetoalcoholicfattyliveracoronaryctastudy
AT dichtlwolfgang coronaryatherosclerosisprofileinpatientswithendstageliverdiseasepriortolivertransplantationduetoalcoholicfattyliveracoronaryctastudy
AT friedrichguy coronaryatherosclerosisprofileinpatientswithendstageliverdiseasepriortolivertransplantationduetoalcoholicfattyliveracoronaryctastudy
AT tilgherbert coronaryatherosclerosisprofileinpatientswithendstageliverdiseasepriortolivertransplantationduetoalcoholicfattyliveracoronaryctastudy
AT feuchtnergudrun coronaryatherosclerosisprofileinpatientswithendstageliverdiseasepriortolivertransplantationduetoalcoholicfattyliveracoronaryctastudy